Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3ED9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,247
Award facts
- Contract value 100% obligated
- $24,247.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,247.40 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of medications and medical devices to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Repatha is a cholesterol-lowering medication used in the treatment of cardiovascular disease and high cholesterol, representing the type of specialized pharmaceutical commodity the company routinely provides through its extensive federal contract portfolio. The competitively awarded contract reflects AmerisourceBergen's established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F3ED9?
SPE2DR26F3ED9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F3ED9 worth?
The government has obligated $24,247 on SPE2DR26F3ED9.
Is contract SPE2DR26F3ED9 an order under another contract?
Yes. SPE2DR26F3ED9 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3ED9 competed?
The extent of competition for SPE2DR26F3ED9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award